- Home
- Sample Business Contracts
- By Company Name
- Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc. Contracts
Sample Business Contracts from Ligand Pharmaceuticals Inc.
- Asset Purchase Agreement - CoPharma Inc. and Marathon Biopharmaceuticals Inc. and Seragen Inc. (Jan 7, 2000)
- Co-Promotion Agreement - Ligand Pharmaceuticals Inc. and Organon Pharmaceuticals USA Inc. (Jan 1, 2003)
- Commercial Supply Agreement and Process Validation Agreement - Seragen inc. and Hollister-Stier Laboratories LLC (Feb 27, 2004)
- Development, Licence and Supply Agreement [Amendment] - Elan Corp. plc and Ligand Pharmaceuticals Inc. (Aug 20, 1999)
- Distributorship Agreement - Ligand Pharmaceuticals Inc. and Elan Pharma International Ltd. (Feb 28, 2001)
- Distributorship Agreement - Ligand Pharmaceuticals Inc. and Ferrer Internacional SA (Mar 26, 1999)
- Employment Agreement - Ligand Pharmaceuticals Inc. and David E. Robinson (May 1, 1996)
- Employment Agreement - Ligand Pharmaceuticals Inc. and Russell L. Allen (Feb 6, 1997)
- Employment Agreement - Ligand Pharmaceuticals Inc. and William Pettit (Nov 4, 1996)
- Incentive Agreement - Monksland Holdings BV, Elan International Services Ltd. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
- Leptin Research, Development and License Agreement - SmithKline Beecham plc and Ligand Pharmaceuticals Inc. (Mar 17, 1998)
- Licence and Supply Agreement - Elan Corp. plc and Elan Management Ltd. and Ligand Pharmaceuticals Inc. (Dec 6, 2002)
- License Agreement - Elan Pharmaceutical Technologies and Ligand Pharmaceuticals Inc. (Sep 28, 1998)
- License Agreement - Ligand Pharmaceuticals Inc. and X-Ceptor Therapeutics Inc. (Jun 30, 1999)
- License Agreement - Salk Institute for Biological Studies and Ligand Pharmaceuticals Inc. (Apr 12, 2002)
- Manufacture and Supply Agreement - Seragen Inc. and Cambrex Bio Science Hopkinton Inc. (Jan 1, 2004)
- Manufacturing and Packaging Agreement - Cardinal Health PTS LLC and Ligand Pharmaceuticals Inc. (Feb 13, 2004)
- Master Lease Agreement - USL Capital Corp. and Ligand Pharmaceuticals Inc. (May 30, 1996)
- Nonexclusive Sublicense Agreement - Seragen Inc., Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. (Sep 8, 1999)
- Option and Wholesale Purchase Agreement - Eli Lilly and Co. and Ligand Pharmaceuticals Inc. (Nov 25, 1997)
- Purchase Agreement - Pharmaceutical Royalties International (Cayman) Ltd. and Ligand Pharmaceuticals Inc. (Dec 30, 2002)
- Purchase Agreement - Pharmaceutical Royalties International (Cayman) Ltd. and Ligand Pharmaceuticals Inc. (Mar 6, 2002)
- Purchase Agreement [Amendment] - Royalty Pharma Finance Trust and Ligand Pharmaceuticals Inc. (Oct 1, 2003)
- Research, Development and License Agreement - Bristol-Myers Squibb Co. and Ligand Pharmaceuticals Inc. (May 19, 2000)
- Research, Development and License Agreement - Organon Co. and Ligand Pharmaceuticals Inc. (Feb 11, 2000)
- Research, Development and License Agreement - Warner-Lambert Co. and Ligand Pharmaceuticals Inc. (Sep 1, 1999)
- Research, Development and License Agreement [Amendment No. 2] - American Home Products Corp. and Ligand Pharmaceuticals Inc. (May 24, 1996)
- Research, Development and License Agreement [Amendment No. 4] - American Home Products Corp. and Ligand Pharmaceuticals Inc. (Sep 9, 1999)
- Royalty Stream Purchase Agreement - Pharmaceutical Partners LLC, Bioventure Investments Kft, Pharmaceutical Royalties LLC, Seragen Inc. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
- SARM Research, Development and License Agreement - TAP Pharmaceutical Products Inc. and Ligand Pharmaceuticals Inc. (Jun 22, 2001)
- Separation Agreement and General Release - Ligand Pharmaceuticals Inc. and Thomas H. Silberg (Jul 7, 2003)
- Settlement Agreement and Mutual General Release - La Jolla Cancer Research Foundation, SelectRA Pharmaceuticals Inc. and SRI International, Ligand Pharmaceuticals Inc., Allergan Ligand and Allergan Ligand Retinoid Therapeutics Inc. (Aug 23, 1995)
- Settlement Agreement and Mutual Release of All Claims - Ligand Pharmaceuticals Inc. and Pfizer inc. (Apr 22, 1996)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Eric S. Groves (Aug 23, 1999)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Giambattista Aliprandi (May 17, 2001)
- Severance Agreement - Ligand Pharmaceuticals Inc. and James J. L'Italien (Jun 26, 2002)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Martin Meglasson (Feb 26, 2004)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Paul V. Maier (Jul 1, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Philip A. Duffy (Dec 9, 1999)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Ronald C. Eld (Jul 1, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Steven D. Reich (Jan 5, 1998)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Thomas H. Silberg (Jan 17, 2000)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Tod G. Mertes (May 20, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Warner R. Broaddus (Dec 13, 2001)
- Severance Agreement - Ligand Pharmaceuticals Inc. and William A. Pettit (Jul 1, 2003)
- Stock Purchase Agreement - Ligand Pharmaceuticals Inc. (Jan 5, 2001)
- Sublicense Agreement [Amendment No. 3] - Ligand Pharmaceuticals Inc. and Retrophin Inc. (Feb 27, 2015)
- Sublicense Agreement [Amendment No. 4] - Ligand Pharmaceuticals Inc., Pharmacopeia LLC and Retrophin Inc. (Sep 17, 2015)
- Supply and Development Agreement - Ligand Pharmaceuticals Inc., Seragen Inc. and CoPharma Inc. (Jan 7, 2000)